Health
Coronavirus vaccine by AstraZeneca begins late-stage US study – 7NEWS.com.au
The company enlisted by Australia as its primary hope for a vaccine has announced a promising step.
AstraZeneca has begun enrolling adults for a US-funded, 30,000-subject late-stage study of its high profile COVID-19 vaccine candidate.
Trial participants will receive either two doses of the experimental vaccine, dubbed AZD1222, four weeks apart, or a placebo, the company said on Monday.
Should the trials prove successful, Australians may be in line to receive the AstraZeneca vaccine.
The trial is being conducted under the US governments Operation Warp Speed program.
The program aims to acc…
-
Noosa News22 hours agoMan dies after stabbing in inner-city unit
-
Noosa News21 hours agoBrisbane man, 39, dies after stabbing at inner city home in early morning attack, prompting investigation
-
Noosa News19 hours agoHomicide investigation launched into stabbing death of 39-year-old Brisbane man at Bowen Hills apartment
-
General12 hours agoAlbo and Dutton do battle for the Port of Darwin